Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2022-12-08 00:00:00 ET · period of report 2022-12-07 · accession 0001127602-22-027093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-08 | 2022-12-07 | MAIA | Gryaznov Sergei | CSO | M - OptEx | $1.83 | +10.0K | 44.5K | +29% | +$18.3K |
| D | 2022-12-08 | 2022-12-07 | MAIA | Gryaznov Sergei | CSO | M - OptEx | $0.00 | -10.0K | 40.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-07 | M | A | 10,000 | $1.83 | 44,511 | D | — | — | |
| 2 | Derivative | Stock Options | 2022-12-07 | M | D | 10,000 | $0.00 | 40,000 | D | $1.83 · — to 2031-04-15 | 10,000 Common Stock | (F1) Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 36 equal monthly instalments beginning on January 1, 2021. |